Publications by authors named "A Setoguchi"

Fat embolism syndrome (FES) occurs when fat droplets from bone marrow or adipose tissue enter the circulation due to bone fractures or surgical interventions. It typically develops 12 to 72 hours after injury. However, fulminant FES, characterized by its rapid onset, is rare and can rapidly progress to a life-threatening condition.

View Article and Find Full Text PDF

A 67-year-old woman was admitted to our hospital because of a complete right bundle branch block. She had been treated with minocycline for skin sarcoidosis and her symptoms had ameliorated four years previously. Gallium scintigraphy revealed an abnormal uptake in the heart but not in the skin or lungs.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the gene expression profiles of dogs with high-grade B-cell lymphoma who underwent chemotherapy, focusing on those that either relapsed early or achieved remission.
  • - Researchers analyzed 25 cases and identified 179 differentially expressed genes (DEGs), highlighting specific genes related to immune signaling and tumor interactions that differed between dogs that relapsed and those that did not.
  • - Notably, genes like CCL4 were downregulated in the relapse group, while genes such as CD3E, ITK, and LAT were upregulated, suggesting that tumor and immune cell interactions play a crucial role in the effectiveness of chemotherapy.
View Article and Find Full Text PDF

A 24-year-old man was admitted to our hospital because of severe heart failure. Although he was treated with diuretics and positive inotropic agents, his heart failure progressed. An endomyocardial biopsy revealed iron deposition in his myocytes.

View Article and Find Full Text PDF

Background: The CyberKnife system features a robotically-positioned linear accelerator to deliver real-time image-guided stereotactic ablative body radiotherapy (SABR). It achieves steep dose gradients using irradiation from hundreds of different directions and increases the central dose of the gross tumor volume (GTV) without increasing the marginal dose to the planning target volume. We evaluated the effectiveness and safety of SABR with a central high dose using CyberKnife for metastatic lung tumors.

View Article and Find Full Text PDF